REPLIGEN CORP
RGEN·759916109·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G
RGEN (REPLIGEN CORP) is held by 186 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($706.1M), PRICE T ROWE ASSOCIATES INC /MD/ ($574.7M), FMR LLC ($340.1M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 109 funds bought RGEN.
186
Holders
(19 Elite)
$6.4B
Total Value
53% (207)
Consensus
109 buying - 98 selling
13F: Insider & Congress:
Who's Trading
InsiderGKGarland Jason KSell $106KJun 25, 2026
InsiderMPMUIR GLENN PExercise 2K shMay 7, 2026
InsiderDRDouglass Brian RobbTax 334 shMay 7, 2026
InsiderLOLoeillot OlivierSell $536KApr 21, 2026
Showing 1-20 of 218
1 / 11
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer